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Abstract
Background: It has been noted that the African American population in the U.S. bears
disproportionately higher cancer morbidity and mortality rates than any racial and ethnic group for
most major cancers. Many studies also document that decreased longevity is associated with low
educational attainment and other markers of low socioeconomic status (SES), both of which are
prevalent in African American communities across the nation. Evidence suggests that this
phenomenon may be due to attitudes that reflect a lack of knowledge surrounding facts about
cancer awareness and prevention. This study was designed to yield data concerning the general
population's attitudes toward cancer, taking into consideration racial and/or socioeconomic
differences in the population studied.
Results: Two hundred and fifteen subjects participated in the survey, of which 74% (159/215)
defined themselves as African-American, 20% were White, and 6% were of other races. While only
38% of the study population was able to identify at least 5 risk factors associated with cancer, a
lower proportion of African Americans identified at least 5 risk factors than whites (34% vs. 53%,
p = 0.03). In addition, a slightly higher percentage of African Americans (10%) were not aware of
the definition of a clinical trial when compared to whites (8%, p > 0.1). Of those aware of the
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with 53% answering no to participation compared to 15% of whites (p = 0.002).
Conclusion: When comparing results to a similar study conducted in 1981, a slight increase in
cancer knowledge in the African American population was observed. Our results suggest that while
knowledge of cancer facts has increased over the years amongst the general population, African
Americans and lower income populations are still behind. This may affect their risk profile and
cancer early detection.
Background
Marked disparities exist in cancer incidence and mortality
among minorities when compared with the majority Cau-
casian population nationwide [1]. African Americans, in
particular, have disproportionately higher incidence and
mortality rates than any racial group for most cancers in
the U.S. African American men have the highest death
rates for lung, colon, and prostate cancer; and black
women have the highest death rates for colon and breast
cancer [2].
Even with an abundance of materials readily available
about cancer, cancer is still poorly understood in African
American communities. Coupled with lower levels of
education and related lower occupational status and
income, African Americans often face barriers that result
in lower obtainment of health information. In cases
where information is made available, studies have shown
that prevention materials are often ineffective [3]. Many
cancer prevention strategies are aimed at the majority
class i.e. white, educated, middle-class individuals [3].
The same messages that may resonate with this popula-
tion do not necessarily carry the same influence for Afri-
can American underserved populations [3,4]. Many
cancer education materials are culturally insensitive and
irrelevant to many underprivileged African Americans.
Studies have shown that medically underserved ethnic
minorities have, in general, less knowledge about cancer
than do whites [1]. A 2005 national population-based US
study found that over 25% of Hispanics and 18% of Afri-
can Americans (compared with 14% of whites) believed
there was nothing they could do to reduce their risk of
cancer [5]. Another study using data from the National
Interview Health Survey examined the association
between established risk factors for cancer (e.g. age, sex,
education, income, family, smoking, alcohol use, body
mass index, and physical activity) and perceived cancer
risk in a sample of 32,374 asymptomatic adults age 18
and older. Researchers found that racial and ethnic minor-
ities were less likely to perceive cancer risk when com-
pared with non-Hispanic white populations [6]. Less
knowledge and poor perception of cancer facts contrib-
utes to the higher morbidity and mortality rates observed
in minority, especially African American communities.
The purpose of this study was to examine knowledge and
perceptions related to cancer prevention and awareness in
adults ages 18 and over. In particular, we are interested in




The study survey consisted of 12 questions aimed at
assessing the participant's knowledge of cancer screening
and cancer risk. Sociodemographic variables including
gender, age, race/ethnicity, education level achieved, and
yearly household income were collected. Participant's
names and other identifiable information were not
recorded in this survey. The study protocol was approved
by the University of Pittsburgh Institutional Review
Board.
Survey distribution
Subjects from the adult general population, 18 years and
older, were invited to participate in this study. Individuals
from the general public in the McKeesport and Pittsburgh,
PA areas were asked to participate in the survey at various
locations where events sponsored by the University of
Pittsburgh Medical Center (UPMC) were being held. This
included church events, health fairs, and community fes-
tivals. In addition, permission was granted to hand out
surveys to UPMC staff and volunteers of the Hillman Can-
cer Center in Pittsburgh, PA.
Surveys completed by the general public from the Hamp-
ton and Richmond, VA area were administered by student
volunteers at Hampton University as part of a collabora-
tive training program between the University of Pitts-
burgh Cancer Institute and Hampton University. The
students administered the surveys to the general public at
various locations throughout the Hampton, VA and Rich-
mond, VA communities (such as laundry mats, police sta-
tions, churches, and supermarkets).
Approximately 400 surveys were distributed across each
location and a total of 215 surveys were collected and ana-
lyzed.Page 2 of 7
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Comparisons of proportions between African-American
and Caucasian subjects were performed after adjusting for
income and education level using STATA SE (version 10)
statistical software (StataCorp LP, College Station, TX).
A cluster analysis was performed on a total of six ques-
tions that were true or false and cancer screening ques-
tions. Each question fell into one of four categories, early
detection knowledge (one question qualified), risk/
screening knowledge (three questions qualified), treat-
ment perception (one question qualified), and cancer per-
ception (one question qualified). Each cluster that was
created was then given a score based on level of knowl-
edge and positive perception in each question category.
For early detection knowledge and risk/screening knowl-
edge questions, if >50% of subjects chose the correct
answer, the cluster received a score of one, correlating
with more knowledge. If <50% of subjects chose the cor-
rect answer, the cluster received a score of zero, correlating
with less knowledge. The same scoring system was then
used for treatment perception and cancer perception
questions. Each cluster was then characterized based on
race/ethnicity, education level, income level, gender, and




Demographic characteristics are presented in Table 1,
according to self-reported race. African Americans com-
prised the majority of the study population (74%), while
Whites accounted for 20%. The remaining 6% consisted
of other races. When taking into account education level,
there is a statistically significant difference between Afri-
can Americans and Whites who have completed high
school or less (13% vs. 0%, p-value = 0.01). A statistically
significant higher percentage of Whites (100%) have com-
pleted a post-secondary education than African Americans
(87%; p < 0.0001). In relation to household income, a
greater percentage of African Americans (62%) have a
yearly household income of less than $35,000.00 com-
pared to Whites (37%; p = 0.003). The percentage of indi-
viduals with a yearly household income greater than
$55,000.00 is also statistically different between Whites
and African Americans (44% vs. 21%, p = 0.003).
Assessments of risk factor knowledge and cancer 
perception
Participants were first asked to identify risk factors associ-
ated with cancer. Table 2 depicts the results according to
race, and adjusted for annual household income and edu-
cation level. Whites were better able to identify at least five
risk factors related to cancer occurrence than African
Americans (p-value = 0.03). Analysis of individual
answers show that Whites were better able to identify age
(65% vs. 33%, p = 0.0005) and unhealthy diet (77% vs.
53%, p = 0.01) as risk factors than African Americans.
Table 3 summarizes survey responses to selected ques-
tions. These proportions were also calculated after adjust-
ing for income and education. The first question inquired
about treatment methods for individuals diagnosed with
cancer. Whites were better able to identify all three forms
of standard treatment than African Americans (60% vs.
17%, p = 0.0039).
Subjects were next asked to express the feeling that comes
to mind when mentioned the words "clinical trial". Over
half of the entire study population, 54%, answered hope-
ful. African Americans were slightly more likely to answer
"none, have never heard of this" than Whites (10% vs.
Table 1: Demographic variables stratified by race/ethnicity.
N(%) African-Americans N (%) Caucasians N (%) Other N (%) p-value*
Study Population
Gender
215 (100) 159 (74) 43 (20) 13 (6)
Male 77 (35) 57 (36) 13 (30) 7 (54)
Female 138 (65) 102 (64) 30 (70) 6 (46)
Age
18–35 105 (49) 79 (50) 19 (44) 7 (54)
36–55 62 (29) 47 (30) 11 (26) 4 (31)
56+ 48 (22) 33 (21) 13 (30) 2 (15)
Education Level
High school or less 23 (11) 21 (13) _ 2 (15) 0.01
Post-secondary education 192 (89) 138 (87) 43 (100) 11 (85) <0.0001
Annual household income
Less than $35, 000 123 (57) 99 (62) 16 (37) 8 (62) 0.003
$35, 000 to $55, 000 34 (16) 26 (16) 8 (19) _
Greater than $55, 000 58 (27) 34 (21) 19 (44) 5 (38) 0.003
*p-value shows statistically significant differences between African-Americans and Caucasians; N = number.Page 3 of 7
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participate in a clinical trial. A higher proportion of Afri-
can Americans subjects answered "no" compared to White
subjects (53% vs. 15%, p = 0.002).
Male subjects were asked if they have or would consider
being screened for prostate cancer. Adjusting for income
and education, 50% of the population of White males
answered yes, while 60% of African American men
answered yes. Fifty percent of White males answered no
and 39% of African American men answered no. Overall,
subjects noted mostly young age (59%) and lack of insur-
ance (29%) as reasons for not being screened (data not
shown).
Female subjects were asked if they have or would consider
being screened for breast cancer. The entire population of
White females answered yes, while the majority of African
American females (91%) answered yes, 6% answered no,
and 3% answered not sure. The majority of the popula-
tion noted lack of insurance (67%) and fear of results
(17%) as reasons for not being screened (data not
shown).
Subjects were then asked to identify sources for additional
information regarding cancer information. The majority
of the population in both Whites (83%) and African
Americans (77%) identified all three corrected sources
(Table 3).
Cluster analysis
The cluster analysis was then performed. A total of five
clusters were created; Table 4 displays each cluster scores
based on the model previously outlined. Clusters #3 and
#5 scored the highest with three points accrued each; thus
representing subjects with more knowledge and positive
perception of cancer. Cluster #3 scored 2 points in knowl-
edge of risk/screening and 1 in treatment/perception,
Table 2: Identification of risk factors stratified by race/ethnicity.
N (%) African Americans* Caucasians* p-value§
Study Population 215 (100) 159 (74) 43 (20)
Answer Choices
Smoking 182 (85) 150 (94) 42 (98)
Family History of Smoking 188 (87) 134 (84) 43 (100)
Heavy Alcohol Consumption 105 (49) 72 (45) 23 (53)
Age 86 (40) 52 (33) 28 (65) 0.0005
Obesity 103 (48) 73 (46) 23 (53)
Unhealthy Diet 127 (59) 85 (53) 33 (77) 0.01
Selected at least 5 risk factors 82 (38) 54 (34) 23 (53) 0.03
*Prevalence adjusted for annual household income and education level. §p-value shown only when there is a statistically significant difference 
between African Americans vs. Caucasians.
Table 3: Selected responses to survey stratified by race/ethnicity
Total pop.
(n/N)
African Americans* Caucasians* p-value§
What kind of treatment is available for individuals diagnosed with 
cancer?
Answer: Identified radiation, chemotherapy, and surgery 156/215 17% (58.4–73.9) 60% (76.0–97.1) 0.0039
What feeling comes to mind when you hear the words "clinical trial?"
Answer: Hopeful 116/215 53% (45.6–61.2) 62% (45.9–75.1)
None, have never heard of this 20/215 10% (6.0–16.3) 8% (2.7–22.9)
If asked to participate in a clinical trial testing a new form of treatment, 
would you participate?
Answer: No 148/215 53% (43.1–63.9) 15% (5.4–35.0) 0.002
If you are a male, have you been screened or plan to be screened for 
prostate cancer?
Answer: Yes 30/54 60% (45.5–74.0) 50% (11.8–88.0)
Answer: No 24/54 39% (26.0–54.5) 50% (12.0–88.2)
Where can you find additional information regarding facts about cancer?
Answer: Identified Doctor or Nurse, Cancer Information Services, American Cancer Society 165/215 77% (70.1–83.6) 83% (67.5–92.3)
*Prevalence adjusted for annual household income and education level. §p-value shown only when there is a statistically significant difference 
between African Americans vs. Caucasians. n = number of subjects that provided a specific answer; N = number of total populationPage 4 of 7
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1 in treatment perception, and 1 in cancer perception.
Cluster #2 had the lowest total score, scoring zero in each
question category. Therefore Cluster #2 represents sub-
jects with the least knowledge and negative perception of
cancer.
Table 5 then characterizes each cluster group. Cluster #2
has the highest proportion of African Americans and the
lowest proportion of Whites, and the highest proportion
of females and the lowest proportion of males. Cluster #3
contains the highest proportion of males and the lowest
proportion of females. Cluster #5 has the highest propor-
tion of African Americans and the lowest proportion of
Whites, as well as the highest percentage of subjects that
have a post-secondary education and the lowest percent-
age of people with a high school level education.
Discussion
The results of our study show that African Americans are
less knowledgeable about risk factors related to cancer
occurrence, knew less about methods of treatment, and
have less knowledge and more negative perceptions of
clinical trials in comparison to Whites. A similar study was
published in 1981 in CA Cancer J Clin, where a nation-
wide sample of 750 black American men and women
were interviewed and compared with the general popula-
tion in another ACS-sponsored study [7]. Results from
this study found that lower income black Americans gen-
erally knew less about cancer and were less exposed to
cancer information than Whites. Black Americans were
Table 4: Knowledge and perception cluster scores
Early detection knowledge
(max score = 1)
Risk/screening knowledge
(max score = 3)
Treatment perception
(max score = 1)
Cancer perception
(max score = 1)
Cluster #
1 1 1 0 0
2 0 0 0 0
3 0 2 1 0
4 0 2 0 0
5 0 1 1 1
For the knowledge questions: >50% of subjects chose the correct answer, the score = 1, more knowledgeable
<50% of subjects chose the correct answer, the score = 0, less knowledgeable
For the perception questions: >50% of subjects answered in the affirmative, the score = 1, positive perception
<50% of subjects answered in the affirmative, the score = 0, negative perception
Table 5: Cluster description
1 2 3 4 5
Race
Caucasian 27.0% 36.0% 15.0% 17.0% 12.0%
African American 68.0% 61.0% 79.0% 75.0% 81.0%
Other 5.0% 3.0% 6.0% 8.0% 7.0%
Education Level
High school or less 9.0% --- 13.0% 4.0% 19.0%
Post-secondary education 91.0% 100.0% 87.0% 96.0% 81.0%
Annual Household Income
Less than $35,000 48.0% 57.0% 62.0% 71.0% 56.0%
$35,000 to $55,000 16.0% 14.0% 13.0% 16.0% 19.0%
More than $55,000 36.0% 29.0% 25.0% 13.0% 25.0%
Gender
Male 38% 30% 41% 32% 37%
Female 62% 70% 59% 68% 63%
Age
18–35 58% 45% 49% 39% 51%
36–55 23% 30% 29% 41% 22%
56+ 19% 25% 22% 20% 27%Page 5 of 7
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knew little about prostate cancer, were pessimistic about
methods of treating cancer, and underestimated the prev-
alence of cancer. Comparing our results to those of this
study, some positive changes are noticed. African Ameri-
can men exhibit knowledge of the importance of prostate
cancer by having been or expressing a want to be screened
for prostate cancer in the future. African Americans also
show greater knowledge of cancer risk by recognizing that
minorities are at greater risk of cancer. Although not at the
same magnitude, our results reflect those of the previous
study 27 years later. These results highlight the great need
for cancer education efforts in African American commu-
nities, particularly in underserved areas.
The lack of knowledge and poor perception of cancer is
partly responsible for behaviors that can increase cancer
risk in minorities. Behavioral factors have long been rec-
ognized as significant influences of cancer incidence and
cancer-related outcomes [8]. There is strong evidence that
reductions in cancer mortality are linked with change in
behavioral risk factors, such as smoking, diet, and adher-
ence to cancer screening tests. Some researchers estimate
that if people were to follow currently available recom-
mendations for cancer prevention and early detection, US
national cancer mortality could be reduced by as much as
60% [6]. Information on reducing cancer risk is needed
for African Americans that is suited to their needs and can
be applied to their lifestyles. Individuals benefit from
health information that reflects their cultural back-
grounds, values, and belief systems [9]. For example, a
study performed by Williams et al. concluded that pho-
topictorials, or pictorial representations with captions,
depicting the process of mammography for Black women
were culturally acceptable and diminished women's fears
and embarrassment about cancer screening [2,10]. Impor-
tantly noted in the previous study as well as in additional
literature, Black Americans are interested in cancer educa-
tion [7].
Teaching underserved African Americans about clinical
trials may contribute to removing false beliefs about can-
cer and its treatment. Mistrust of clinical research and the
medical profession as a whole have presented as barriers
to minority, particularly African American, participation
in clinical trials [11]. Educational sessions on the modali-
ties used to treat cancer and the role of clinical trials in the
current treatment of cancer would be most useful. Previ-
ous studies have demonstrated that community education
and recruitment is more effective compared with that
from the health care system [11]. The involvement of
leaders and organizations well-respected in minority com-
munities may help ease mistrust and may result in more
cooperation and more desire to learn about and partici-
pate in clinical trials.
The cluster analysis performed on this data did not iden-
tify a specific profile that could describe knowledge and
perception, other than education. A possible reason for
this is the small study population. Men and women were
asked if they had been or plan to be screened for prostate
and breast cancer respectively. The overall response rate to
these questions was low; therefore, we were unable to cal-
culate proportions according to race while adjusted for
income and education.
For a more accurate description of the attitudes of the gen-
eral population, subject numbers should increase and
include a more balanced representation from each demo-
graphic. For future study, additional questions pertaining
to risk factors, e.g. possible engagement in behaviors that
increase cancer risk and willingness to alter those behav-
iors, should also be explored. Perceptions of cancer infor-
mation, e.g. is information relatable to subjects' lifestyle
and background, to determine more effective methods of
communication should be considered as well.
Conclusion
While knowledge and positive perceptions of cancer have
overall increased in the general population, underserved
African Americans are still behind. Cancer prevention
efforts tailored to the needs of individuals in underserved
communities is a priority for public health educators.
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